Yet another evidence discourages antihypertensives for moderate/mild chronic hypertension in pregnancy

  • J Matern Fetal Neonatal Med

  • from Antara Ghosh
  • Clinical Summaries
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • Meta-analysis of pregnant women with mild to moderate chronic hypertension indicates that lowering of mean arterial pressure with antihypertensive therapies has no significant effects on risk for pre-eclampsia.
  • No significant reduction was observed for risk for small for gestational age (SGA) neonates too.

Why this matters

  • Guidelines have been reluctant to recommend antihypertensive medications for mild to moderate hypertension because of lack of evidence supporting improved perinatal outcomes.
  • Findings are concordant with a previous study that found no difference between a tight (85 mmHg) and less-tight (100 mmHg) diastolic BP control on risk for pre-eclampsia and SGA.

Study design

  • Meta-analysis evaluated 6 randomised controlled trials (RCTs) involving 495 pregnant women with mild to moderate chronic hypertension in pregnancy.
  • Funding: Fetal Medicine Foundation.

Key results

  • Mean arterial pressure was significantly lower in women who received antihypertensive therapy vs those who received placebo or no treatment (mean difference, −4.2 mmHg; P=.0005).
  • However, no significant reduction was observed in risk for pre-eclampsia (relative risk [RR], 1.03; P=.90) or SGA (RR, 1.01; P=.99).

Limitations

  • Risk for bias.
  • High heterogeneity among included studies.